Clinical research
Clinical Research Map
Clinical trial sites: one pin for each physical site that hosts trials, placed from the address on the trial registration.
- Trial site
- Group of pins (click to zoom)
Showing 107 located sites.
Each pin is one trial site, placed on the map from the address on the trial registration, so it shows part of where trials are run, not all of it. A site with no located address has no pin. A site with a public page on Pharma Observatory links to it; other sites show name, place and trial count only.
Looking for contract research suppliers and CROs? Visit Contract Research Map
Trial sites by region
Select a bar to filter by region.
Log scale: bar lengths compare orders of magnitude, not proportions.
| Category | Trial sites |
|---|---|
| Europe | 107 |
Top countries
Country of the site's address. Select a bar to filter.
Log scale: bar lengths compare orders of magnitude, not proportions.
Bar colour shows the country's region, as in the chart by region.
| Category | Trial sites |
|---|---|
| United States | 12,440 |
| France | 1,867 |
| China | 1,612 |
| Germany | 1,389 |
| United Kingdom | 1,087 |
| Spain | 1,076 |
| Italy | 1,044 |
| Canada | 932 |
Trial sites
107 sites. Sites with a public page link to it on Pharma Observatory.
-
GSK Investigational Site 49 trials
-
Sanofi-Aventis Administrative Office 43 trials
-
Hospital CUF Porto 40 trials
-
Hospital Santa Maria 36 trials
-
Hospital Garcia de Orta 33 trials
-
Hospital CUF Descobertas 32 trials
-
Centro Hospitalar do Porto 31 trials
-
GSK Investigational Site 31 trials
-
Pfizer Investigational Site 31 trials
-
Research Site 27 trials
-
Research Site 27 trials
-
Champalimaud Foundation 25 trials
-
Hospitais da Universidade de Coimbra 24 trials
-
Pfizer Investigational Site 24 trials
-
Pfizer Investigational Site 24 trials
-
Research Site 24 trials
-
Hospital da Luz Lisboa 23 trials
Explore the data behind the map on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.